Abstract:Background Toxoplasmosis, caused by an obligate intracellular protozoan parasite Toxoplasma gondii , has been a serious clinical and veterinary problem. Effective DNA vaccines against T. gondii can prevent and control the spread of toxoplasmosis, which is important for both human health and the farming industry. The T. gondii 14-3-3 protein has been proved to be antigenic and immunogenic and was a potential vaccine candidate against toxoplasmosis. In this study, we evaluated the immune responses induced by recombinant plasmids encoding T. gondii surface antigen 1 (SAG1) and 14-3-3 protein by immunizing BALB/c mice intramuscularly. Methods In the present study, BALB/c mice were randomly divided into five groups, including three experimental groups (pSAG1, p14-3-3 and pSAG1/14-3-3) and two control groups (PBS and pBudCE4.1), and were immunized intramuscularly three times. The levels of IgG antibodies and cytokine production in mouse sera were determined by enzyme-linked immunosorbent assays (ELISA). Two weeks after the last immunization, all mice were challenged intraperitoneally (i.p.) with 1×10 4 tachyzoites of T. gondii and the survival time of mice was observed and recorded every day. Results Mice vaccinated with pSAG1, p14-3-3 or pSAG1/14-3-3 developed high levels of IgG2a and gamma interferon (IFN-γ) and low levels of interleukin-4 (IL-4) and interleukin-10 (IL-10) compared to control groups (PBS or pBudCE4.1), which suggested a modulated Th1 type immune response (P<0.05). After intraperitoneal challenge with 1×10 4 tachyzoites of T. gondii (RH strain), the survival time of mice in experimental groups was longer than control groups (P<0.05). Mouse immunized with pSAG1/14-3-3 induced a higher level of IgG antibody response and significantly prolonged the survival time when compared with pSAG1 or p14-3-3 (P<0.05). Conclusions The study suggested that T. gondii 14-3-3 protein can induce effective immune responses in BALB/c mice and was a novel DNA vaccine candidate against toxoplasmosis, and the immune protective efficacy elicited by SAG1 gene was also demonstrated. Our results also showed multi-gene vaccine significantly enhanced immune responses and protective efficacy and was superior to the single-gene vaccine.

Evaluation of the Immune Response Induced by Dna Vaccines Expressing Mif and Mcd-1 Genes of Trichinella Spiralis in Balb/C Mice

Immune Responses in Mice Vaccinated with a DNA Vaccine Expressing Serine Protease-Like Protein from the New-Born Larval Stage Oftrichinella Spiralis

Protective Immune Response Induced by Co-Immunization with the Trichinella Spiralis Recombinant Ts87 Protein and a Ts87 DNA Vaccine.

Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.

Evaluation of Protective Effect of Multiantigenic DNA Vaccine Encoding MIC3 and ROP18 Antigen Segments of Toxoplasma Gondii in Mice.

Induction of Protective Immunity by DNA Vaccination in Mice by DNA Vaccination with a Eukaryotic Expression Plasmid Encoding the Compound Gene of Toxoplasma Gondii Antigen and the A2/B Subunit of Cholera Toxin

Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.

Protective Effect of a Prime-Boost Strategy with the Ts87 Vaccine Against Trichinella Spiralis Infection in Mice.

Protective Immunity Induced in Mice by Multiantigenic DNA Vaccine with Genes Encoding SAG1 and MIC8 of Toxoplasma Gondii.

Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice

Oral Vaccination of Mice With Trichinella spiralis Putative Serine Protease and Murine Interleukin-4 DNA Delivered by Invasive Lactiplantibacillus plantarum Elicits Protective Immunity

Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice

Immunity Induced by Dna Vaccine of Plasmid Encoding the Rhoptry Protein 1 Gene Combined with the Genetic Adjuvant of Pcifn-Gamma Against Toxoplasma Gondii in Mice

Protective Immunity Against Trichinella Spiralis Infection Induced by a Multi-Epitope Vaccine in a Murine Model

Evaluation on immunizing effect and route of plural DNA vaccine to Toxoplasma gondii

Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.

Study on Immunogenicity and Protective Efficacy of Tetravalent Combination M-Tuberculosis Dna Vaccinea

Immunological response and protection of mice immunized with plasmid encoding Toxoplasma gondii glycolytic enzyme malate dehydrogenase.

Immune Response Elicited by Recombinant Mycobacterium smegmatis Expressed HBV Fused Gene in Mice in vivo

Immune response and protective efficacy against homologous challenge in BALB/c mice vaccinated with DNA vaccine encoding Toxoplasma gondii actin depolymerizing factor gene.

Vaccination of Mice with an Antigenic Serine Protease-Like Protein Elicits a Protective Immune Response AgainstTrichinella Spiralisinfection